Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...

A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, called Galleri, failed to lower the number of people diagnosed ...

Grail, a healthcare company seeking to help more patients detect cancer early while it can still be cured, has had a difficult five years, facing job cuts, restructuring, and a botched acquisition.